128 related articles for article (PubMed ID: 16082206)
21. Whole-genome cartography of p53 response elements ranked on transactivation potential.
Tebaldi T; Zaccara S; Alessandrini F; Bisio A; Ciribilli Y; Inga A
BMC Genomics; 2015 Jun; 16(1):464. PubMed ID: 26081755
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional functionality of germ line p53 mutants influences cancer phenotype.
Monti P; Ciribilli Y; Jordan J; Menichini P; Umbach DM; Resnick MA; Luzzatto L; Inga A; Fronza G
Clin Cancer Res; 2007 Jul; 13(13):3789-95. PubMed ID: 17606709
[TBL] [Abstract][Full Text] [Related]
23. Initiation of human astrocytoma by clonal evolution of cells with progressive loss of p53 functions in a patient with a 283H TP53 germ-line mutation: evidence for a precursor lesion.
Fulci G; Ishii N; Maurici D; Gernert KM; Hainaut P; Kaur B; Van Meir EG
Cancer Res; 2002 May; 62(10):2897-905. PubMed ID: 12019170
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional induction of protein kinase C delta by p53 tumor suppressor in the apoptotic response to DNA damage.
Dashzeveg N; Yogosawa S; Yoshida K
Cancer Lett; 2016 Apr; 374(1):167-174. PubMed ID: 26884258
[TBL] [Abstract][Full Text] [Related]
25. Interactions between the tumor suppressor p53 and immune responses.
Menendez D; Shatz M; Resnick MA
Curr Opin Oncol; 2013 Jan; 25(1):85-92. PubMed ID: 23150340
[TBL] [Abstract][Full Text] [Related]
26. Differential recognition of response elements determines target gene specificity for p53 and p63.
Osada M; Park HL; Nagakawa Y; Yamashita K; Fomenkov A; Kim MS; Wu G; Nomoto S; Trink B; Sidransky D
Mol Cell Biol; 2005 Jul; 25(14):6077-89. PubMed ID: 15988020
[TBL] [Abstract][Full Text] [Related]
27. The p53/microRNA network in cancer: experimental and bioinformatics approaches.
Hünten S; Siemens H; Kaller M; Hermeking H
Adv Exp Med Biol; 2013; 774():77-101. PubMed ID: 23377969
[TBL] [Abstract][Full Text] [Related]
28. Transcriptional regulation by p53: one protein, many possibilities.
Laptenko O; Prives C
Cell Death Differ; 2006 Jun; 13(6):951-61. PubMed ID: 16575405
[TBL] [Abstract][Full Text] [Related]
29. Evolution of p53 in hypoxia-stressed Spalax mimics human tumor mutation.
Ashur-Fabian O; Avivi A; Trakhtenbrot L; Adamsky K; Cohen M; Kajakaro G; Joel A; Amariglio N; Nevo E; Rechavi G
Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12236-41. PubMed ID: 15302922
[TBL] [Abstract][Full Text] [Related]
30. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Bond GL; Hu W; Bond EE; Robins H; Lutzker SG; Arva NC; Bargonetti J; Bartel F; Taubert H; Wuerl P; Onel K; Yip L; Hwang SJ; Strong LC; Lozano G; Levine AJ
Cell; 2004 Nov; 119(5):591-602. PubMed ID: 15550242
[TBL] [Abstract][Full Text] [Related]
31. Identification of p53-target genes in Danio rerio.
Mandriani B; Castellana S; Rinaldi C; Manzoni M; Venuto S; Rodriguez-Aznar E; Galceran J; Nieto MA; Borsani G; Monti E; Mazza T; Merla G; Micale L
Sci Rep; 2016 Sep; 6():32474. PubMed ID: 27581768
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.
Yoon H; Liyanarachchi S; Wright FA; Davuluri R; Lockman JC; de la Chapelle A; Pellegata NS
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15632-7. PubMed ID: 12438652
[TBL] [Abstract][Full Text] [Related]
33. p53 and human cancer: the first ten thousand mutations.
Hainaut P; Hollstein M
Adv Cancer Res; 2000; 77():81-137. PubMed ID: 10549356
[No Abstract] [Full Text] [Related]
34. Single nucleotide polymorphism in transcriptional regulatory regions and expression of environmentally responsive genes.
Wang X; Tomso DJ; Liu X; Bell DA
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):84-90. PubMed ID: 16002116
[TBL] [Abstract][Full Text] [Related]
35. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
36. Tumor-derived p53 mutants induce oncogenesis by transactivating growth-promoting genes.
Scian MJ; Stagliano KE; Deb D; Ellis MA; Carchman EH; Das A; Valerie K; Deb SP; Deb S
Oncogene; 2004 May; 23(25):4430-43. PubMed ID: 15077194
[TBL] [Abstract][Full Text] [Related]
37. Mathematical model of dynamic protein interactions regulating p53 protein stability for tumor suppression.
Wang H; Peng G
Comput Math Methods Med; 2013; 2013():358980. PubMed ID: 24454532
[TBL] [Abstract][Full Text] [Related]
38. A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans.
Bond GL; Levine AJ
Oncogene; 2007 Feb; 26(9):1317-23. PubMed ID: 17322917
[TBL] [Abstract][Full Text] [Related]
39. p53 genes function to restrain mobile elements.
Wylie A; Jones AE; D'Brot A; Lu WJ; Kurtz P; Moran JV; Rakheja D; Chen KS; Hammer RE; Comerford SA; Amatruda JF; Abrams JM
Genes Dev; 2016 Jan; 30(1):64-77. PubMed ID: 26701264
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53.
Zhang C; Gao C; Kawauchi J; Hashimoto Y; Tsuchida N; Kitajima S
Biochem Biophys Res Commun; 2002 Oct; 297(5):1302-10. PubMed ID: 12372430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
